Verve Therapeutics Inc (VERV)

33.25 +0.10  +0.30% NASDAQ Nov 29, 16:00 33.34 +0.09  +0.27% After-Hours: 20:00 USD

Verve Therapeutics EPS Diluted (TTM):

-8.387 for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

EPS Diluted (TTM) Chart

Export Data
Save Image
Print Image

Historical EPS Diluted (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 -8.387
June 30, 2021 -8.225
March 31, 2021 -1.825
Dec. 31, 2020 -1.567

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (TTM) Benchmarks

Regenxbio Inc -5.17
Krystal Biotech Inc -2.71
Beam Therapeutics Inc -6.88

EPS Diluted (TTM) Range, Past 5 Years

Minimum -8.387 Sep 2021
Maximum -1.567 Dec 2020
Average -5.001


Verve Therapeutics' Q3 Net Loss Shrinks
MT Newswires 11/10 07:51 ET
Top IPO additions to Russell 2000 Index
SA Breaking News 09/17 10:48 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.